Israeli medtech startup X-trodes, which offers a new “smart skin” to monitor sleep, raised a $4.5 million seed round led by Japan Israel High Tech Ventures (Chartered Group), Welltech, and Jeremy Coller. X-trodes, a bio-convergence company that developed wearable technology for advanced electrophysiological measurement and analytics.
Bio-convergence is based on connecting numerous technologies from the fields of biology and engineering. This is a new industry that is expected to form the future base of medicine and remodel the global health industry.
Medtech is basically any new technology that has to do with medical issues. Startup Nations is also known for its medtech startups. Israel has always been a center for medical research and innovation. Now put that together with its startup culture and you have medtech nation.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
One example of this is Aviv Scientific, an Israeli medtech company that conducts research and clinical treatment of age-related cognitive and functional decline to maximize human performance. Last month the firm brought in $40 million in an oversubscribed Series B funding round. Aviv Scientific develops age-related cognitive and functional decline and novel applications of hyperbaric oxygen therapy (HBOT) to maximize human performance.
And just yesterday, Navina, an Israeli medtech startup that offers a clinical platform for primary care, secured $15 million in Series A funding. The Navina solution uses artificial intelligence AI to help doctors make the day to day decisions on their patients’ health care needs.
X-trodes boasts that it has developed the world’s first scalable wireless Smart Skin, a wearable technology for advanced electrophysiological monitoring and analytics that can be used by patients in their natural environment. The device consists of an ultra-soft, dry, multi-electrode patch array system. Its patented technology that aims to reduce hospital and clinic workload and ease patients’ lives.
Ziv Peremen, X-trodes co-founder and CEO said, “In 7 years, there will be more hospitalizations at home than in hospitals. A wide range of laboratory tests available only in hospitals can be performed at home with X-trodes, without compromising their quality or reliability. In terms of our capabilities, muscle recovery and sleep monitoring are just the beginning. We are proud to partner with tier 1 strategic partners that bring our ground breaking products to new patients and doctors around the world.”